ARDA Software for the Detection of mtmDR

Inclusion criteria

• Documented diagnosis of Type I or Type II diabetes mellitus:

meet the criteria established by either the World Health Organization (WHO) or the American Diabetes Association (ADA)

• Age 22 or older
• Understand the study and volunteer to sign the informed consent

Exclusion criteria

• Self-reported visual symptoms and persistent blurred vision (greater than 24 hours); including vision loss that cannot be corrected (e.g. with eye glasses).
• Diagnosed with macular edema, any known retinopathy, radiation retinopathy, or retinal vein occlusion.
• History of laser treatment of the retina or injections into either eye, or any history of retinal surgery.
• Scheduled to undergo the following surgeries before completion of the study imaging: cataract surgery (including any related follow-up procedures) or vitrectomy.
• Currently participating in an interventional study.
• Participant has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure or glycemic control, microphthalmia or previous enucleation, etc.).
• Participant is contraindicated for imaging by fundus imaging system used in the study; e.g.

• Participant is hypersensitive to light (side effect of medication or due to unknown etiology)
• Participant has undergone photodynamic therapy (PDT)
• Previous issues with dilation (angle closure, inability to dilate, allergy to dilation drops).
• Known pregnancy or possibility of pregnancy